Found 2 hits in this display Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Lysophosphatidic acid receptor 1
(Homo sapiens (Human)) | BDBM251715
(US10100018, Example 51 | US9464060, 51)Show SMILES OC(=O)c1ccc(CN(CC2CC2)C(=O)c2ccc(OCc3ccccc3F)cc2)cc1 Show InChI InChI=1S/C26H24FNO4/c27-24-4-2-1-3-22(24)17-32-23-13-11-20(12-14-23)25(29)28(15-18-5-6-18)16-19-7-9-21(10-8-19)26(30)31/h1-4,7-14,18H,5-6,15-17H2,(H,30,31) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description
Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... |
US Patent US10100018 (2018)
BindingDB Entry DOI: 10.7270/Q2PR7Z0N |
More data for this
Ligand-Target Pair | |
Lysophosphatidic acid receptor 5
(Homo sapiens (Human)) | BDBM251715
(US10100018, Example 51 | US9464060, 51)Show SMILES OC(=O)c1ccc(CN(CC2CC2)C(=O)c2ccc(OCc3ccccc3F)cc2)cc1 Show InChI InChI=1S/C26H24FNO4/c27-24-4-2-1-3-22(24)17-32-23-13-11-20(12-14-23)25(29)28(15-18-5-6-18)16-19-7-9-21(10-8-19)26(30)31/h1-4,7-14,18H,5-6,15-17H2,(H,30,31) | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description
Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... |
US Patent US9464060 (2016)
BindingDB Entry DOI: 10.7270/Q23R0RT0 |
More data for this
Ligand-Target Pair | |